Lexol

Quick links to important sections

Lexol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lexol

Property Description
Active Ingredient Labetalol hydrochloride
Forms Tablets, Intravenous Solution
Pharmacological Class Antihypertensive agent, Adrenergic receptor antagonist
General Purpose Management of elevated blood pressure (Hypertension)
Origin Synthetic compound

Defining Lexol: Type, Class, and Identity

Lexol is a prescription-only medication (Rx) whose active ingredient is Labetalol hydrochloride, a synthetic compound used in the comprehensive management of elevated blood pressure (hypertension). It is precisely classified as an antihypertensive agent and an adrenergic receptor antagonist. Labetalol is distinctive because it employs a dual mechanism of action, serving as both a beta-adrenoceptor blocker and a selective alpha1-adrenoceptor blocker. This unique, two-pronged approach differentiates it from traditional single-action agents by simultaneously influencing two key receptor systems involved in blood pressure regulation.

Composition and Available Pharmaceutical Forms

The core composition of Lexol is the single-ingredient product, Labetalol. This active substance is supplied in two primary dosage form(s): a solid oral preparation (tablets) for sustained, routine therapy, and a sterile aqueous solution for intravenous administration. The availability of both forms facilitates use in both chronic maintenance and in situations requiring rapid therapeutic response to high pressure. This versatility is a key feature, supporting the medicine’s use in various clinical settings where control over peripheral vascular resistance is necessary.

Lexol's General Purpose and Core Therapeutic Function

The general purpose of Lexol is to systematically achieve and sustain controlled blood pressure levels. Its core therapeutic function harnesses its dual action to reliably reduce the heart's workload and the tension within the blood vessel walls. This provides a comprehensive strategy for managing the cardiovascular strain associated with chronic high blood pressure.

Regulatory References

  1. MedlinePlus

What side effects are possible with Lexol?

Adverse Reaction Scope

The official safety documents for Lexol categorize potential side effects, known as adverse reactions, based on how frequently they occurred in clinical studies and post-marketing surveillance. These regulatory classifications are vital for understanding the medicine’s risk profile.

Key Adverse Reaction Categories:

  • Frequency-Classified Adverse Reactions: Undesirable effects are officially listed with their documented rate of occurrence.
  • System-Organ-Class (SOC) Groupings: Adverse events are systematically grouped by the body system affected (e.g., Nervous System Disorders, Gastrointestinal Disorders).
  • Serious Adverse Reactions: Events designated by regulatory authorities as life-threatening, requiring hospitalization, or resulting in persistent disability.
  • Safety Restrictions and Limitations: Formal warnings and contraindications placed on the drug’s use.

Frequency Classification (Examples):

  • Very Common (≥1/10): Headache, nausea, or fatigue.
  • Common (≥1/100 to <1/10): Dizziness, rash, or musculoskeletal pain.
  • Rare (1/10,000 to <1/1,000): Severe hypersensitivity reactions (anaphylaxis) or severe hepatic injury.

Serious Adverse Reactions (as documented in regulatory sources):

  • Severe systemic allergic reactions (e.g., angioedema).
  • Signs of significant hepatic dysfunction (e.g., liver failure).
  • Clinically significant cardiovascular events.

Population-Specific Safety Considerations:

  • Hepatic/Renal Impairment: Specific warnings apply to patients with pre-existing liver or kidney dysfunction, which may necessitate careful monitoring or restriction of use.
  • Pregnancy/Lactation: Use is formally restricted or contraindicated based on regulatory risk summaries concerning potential harm to the fetus or infant.

Dose- or Exposure-Related Patterns:

  • The risk of developing certain adverse reactions may be explicitly noted to increase with prolonged use (long-term exposure) or when specific cumulative doses are reached.

Safety-Related Restrictions or Limitations:

  • Contraindications: Lexol is contraindicated in individuals with a known history of hypersensitivity to the active substance or in combination with specific, identified concomitant medications (e.g., strong CYP inhibitors) due to documented safety risks.
  • Safety Monitoring: Official documents define high-level requirements, such as periodic monitoring of specific laboratory tests, without providing detailed clinical advice.

Connection to the Overall Safety Profile

The structured organization of this information, based on governmental documentation, strictly defines the boundaries and conditions for the medicine’s safe application. By classifying all known adverse events by frequency and highlighting specific, rare, serious risks, the official safety profile provides a transparent, factual description of the drug’s potential hazards as determined by global regulatory agencies.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Lexol (Labetalol hydrochloride) is a potentially life-threatening emergency primarily characterized by severe Cardiocirculatory Depression and Central Nervous System (CNS) Toxicity. Official regulatory documentation states that an overdose may manifest as profound hypotension (dangerously low blood pressure), severe bradycardia (slow heart rate), or signs of heart failure, which can rapidly progress to Cardiogenic Shock or Cardiac Arrest.

Official Manifestations and Actions

The most severe documented neurological presentations include convulsions (seizures) and coma. In all cases of suspected overdose, immediate medical attention is mandated. Individuals must contact emergency services or a Poison Control Center right away.

Regulatory agencies note that no specific antidote is known for Labetalol overdose. Consequently, management focuses on symptomatic and supportive treatment, which may involve procedures like gastric lavage or the administration of activated charcoal to limit absorption.

Continuous cardiac monitoring is required, and vital signs must be closely observed in a hospital setting due to the risk of delayed, severe complications. A specific consideration exists for pediatric overdose, where hypoglycemia (low blood sugar) is a frequently documented and critical complication.

Therapeutic Uses of Lexol

Quick Facts: Lexol

  • May be used for the management of high blood pressure (hypertension).
  • May support the treatment of heart-related chest pain (angina pectoris).
  • May be prescribed for high blood pressure during pregnancy.

Lexol is a prescription medication utilized in therapeutic regimens to support cardiovascular health. Its primary use is in the management of high blood pressure, also known as hypertension, a condition where the force of blood against the artery walls is elevated. By supporting blood pressure reduction, the medication may help to reduce the risk of future cardiovascular events such as a heart attack or stroke.

The medication may also be included in the treatment plan for individuals experiencing angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle. In this context, it contributes to easing the workload on the heart, which may assist in managing the frequency of angina episodes. Additionally, a specific use for this compound is the therapeutic management of high blood pressure during pregnancy, when medically indicated and supervised by a healthcare professional.

Eligibility and Restrictions for Use

This section outlines the official eligibility and non-eligibility information for Lexol (fluvastatin) as documented in government regulatory sources. It defines the populations that are permitted to use the medicine and those for whom use is contraindicated.

Populations for Whom Use is Prohibited (Contraindications)

Official regulatory documents state that Lexol must not be used by individuals who meet the following criteria:

  • Active Liver Disease: Patients with active liver disease or unexplained, persistent elevations in serum transaminases (liver enzymes).
  • Hypersensitivity/Allergy: Individuals with a known hypersensitivity or allergic reaction to fluvastatin or any other ingredient in the medication.
  • Pregnancy: Women who are pregnant or who may become pregnant. The drug is contraindicated due to the potential for fetal harm.
  • Lactation: Nursing mothers, as the drug may cause serious adverse reactions in a breastfed infant, and is not recommended.

Eligibility and Restricted Use

Population Group Eligibility Status Official Constraint / Restriction
Adults (General) Generally Eligible Use is allowed unless a formal contraindication exists.
Pediatrics Use Established for Specific Age Safety and efficacy have not been established in children younger than 10 years of age. Use is allowed for pediatric patients aged 10 years and older (specifically for Heterozygous Familial Hypercholesterolemia).
Severe Renal Impairment Restricted / Caution Use requires caution, and doses greater than 40 mg have not been studied in these patients.

Women of childbearing potential should be advised to use effective contraception while taking this medication and must be informed of the potential hazards if pregnancy occurs.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lexol is a brand name most commonly associated with labetalol, an adrenergic receptor blocker used to manage high blood pressure. As a pharmaceutical agent, labetalol may interact with certain other medicines, potentially altering their effects or increasing the risk of adverse reactions. Patients should inform their healthcare professional of all current prescriptions, over-the-counter medicines, and supplements.

Key Drug and Substance Interactions

Interacting Product Category Potential Effect of Interaction
Other Antihypertensives (e.g., calcium channel blockers) Increased risk of low blood pressure (hypotension) or excessively slow heart rate (bradycardia).
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) NSAIDs (like ibuprofen) may diminish the blood pressure-lowering efficacy of labetalol.
Anti-diabetic Medicines (e.g., insulin, oral agents) Labetalol can mask the common symptoms of low blood sugar, such as fast heart rate, making it harder to detect and manage hypoglycemia.
Alcohol May increase the risk of dizziness, low blood pressure, and fainting.

Combinations with other beta-blockers or medicines that affect heart rhythm require careful monitoring. In a different context, the name Lexol may refer to triclosan, a non-drug antimicrobial banned from most consumer antiseptic wash products due to concerns over bacterial resistance and endocrine effects. However, triclosan's interaction profile is distinct from that of the prescription medicine labetalol.

Mechanism of Action

Lexol's action is defined by its function as a dual antagonist of the sympathetic nervous system's key receptors. This mechanism specifically modulates signaling that regulates cardiac output and vascular resistance.

Balanced alpha1 and beta Receptor Blockade

This domain covers how Lexol engages its primary molecular targets—the alpha1 and beta1/beta2 adrenergic receptors—to initiate a dual physiological response. The drug competitively blocks the binding of stimulating catecholamines at these sites. This molecular interference alters the downstream signaling of the sympathetic nervous system that controls both the heart and the peripheral vessels.

Integrated Control of Cardiac Output and Vascular Tone

This domain describes the coordinated mechanistic cascade resulting from the dual receptor blockade. beta1 antagonism reduces the heart’s rate and force (decreasing Cardiac Output), while alpha1 antagonism causes peripheral vasodilation (decreasing Total Peripheral Resistance). This simultaneous modulation of both core hemodynamic factors results in the drug's distinct physiological response.

Interruption of Compensatory Reflexes

This domain addresses the synergy within the mechanism. Vasodilation naturally triggers a body reflex to increase heart rate; however, the simultaneous beta1 blockade inhibits this compensatory acceleration. This integrated action interrupts the baroreceptor-mediated signal for reflex heart rate acceleration. This mechanism contributes to the characteristic simultaneous reduction of heart rate and peripheral resistance.

Dosage and Administration Information

Instruction Map: How to use Lexol

Lexol (Labetalol hydrochloride) is administered via two routes: oral tablets for chronic management and intravenous (IV) injection/infusion for acute blood pressure control in supervised clinical settings. Procedural standards are established for both methods.


Administration Scope Guideline
Route of Administration Oral (tablets) or Intravenous (IV solution).
Timing in Relation to Meals Oral tablets must be taken with food to ensure optimal drug absorption.
Preparation Requirements IV solution may require dilution with common IV fluids (e.g., to 1 mg/mL) prior to continuous infusion.

Dosing Ranges and Regimens

Regimen / Route Starting Dose Maximum Daily Dose
Oral (Routine Use) 100 mg twice daily (b.i.d.) 2400 mg (in divided doses)
IV Bolus (Acute Use) 20 mg over 2 minutes 300 mg cumulative total dose

Frequency and Schedule: Oral dosing is typically twice daily, with adjustments of 100 mg b.i.d. made at intervals of two to three days. IV injections are given at 10-minute intervals until the desired blood pressure response is achieved.

Age-Group Administration Rules: Older adults may require a lower initial dose (e.g., 50 mg b.i.d.) and generally need lower maintenance dosages. Safety and efficacy have not been established for the pediatric population.

Special Procedural Conditions: Patients receiving the IV form must be kept in a supine position during administration. When discontinuing therapy, the dosage must be gradually reduced over a period of one to two weeks, rather than stopped abruptly.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lexol


Evidence for Use in Chronic Hypertension (Oral Tablets)

Research exploring Lexol for long-term high blood pressure management has relied on different study types, primarily Randomized Controlled Trials (RCTs) and comparative clinical studies. Researchers designed these studies to examine how Lexol oral tablets alter systolic and diastolic blood pressure measurements over defined time intervals. Long-term research has explored cardiovascular outcomes such as stroke or heart attack over years, and these findings are used to contextualize the relationship between measured blood pressure alteration and subsequent health events.

However, the current body of research does not fully characterize certain aspects. Comparative evidence directly involving Lexol and all newer classes of blood pressure medications in large-scale trials tracking the longest-term outcomes is not extensively documented. Therefore, statements about the absolute long-term impact on specific cardiovascular events are often drawn from the established association between blood pressure reduction and cardiovascular outcomes, rather than from Lexol-specific trials spanning decades.


Evidence for Use in Acute/Severe Hypertension (Intravenous Solution)

For patients experiencing very high, uncontrolled blood pressure that requires rapid management, such as in a hospital setting, the research has focused on the intravenous (IV) solution of Lexol. Clinical pharmacology studies and smaller comparative trials have been conducted. Research examined outcomes such as the interval of time measured (often in minutes) to observe a specified blood pressure level. Findings indicate that the IV administration was associated with rapid blood pressure alteration in the observed populations, and studies report how blood pressure measurements evolved in these acute care scenarios.


Evidence in Pregnancy-Related Hypertension

Research evidence is available for Lexol in the context of blood pressure management during pregnancy, including gestational hypertension and preeclampsia. Findings describe group patterns related to the alteration and subsequent measured blood pressure readings over the observation period in pregnant patients. However, there is limited information for long-term outcomes regarding the neurodevelopmental follow-up of children exposed to the medicine before birth.

Frequently Asked Questions (FAQ)

Common questions about Lexol (FAQ)

Q: How quickly does Lexol usually start working?

According to regulatory documents, the maximum blood pressure-lowering effect after taking an oral tablet typically occurs within 2 to 4 hours. When establishing a routine, the full physiological response is typically reached within two to three days.


Q: How long does the effect of a Lexol dose typically last?

The duration of the effect varies based on the size of the dose taken. Official information indicates that the blood pressure-lowering effect lasts at least 8 hours following a smaller single oral dose, and more than 12 hours following a larger single oral dose.


Q: Is Lexol considered a permanent cure or a long-term management tool?

Lexol is designed as a long-term management tool. Official patient information notes that while this medication helps control high blood pressure, it is not considered a cure for the condition.


Q: Are there generic versions of Lexol available, and are they the same?

The active ingredient in Lexol, Labetalol, is available in generic versions. Generic products must demonstrate bioequivalence to the original drug, meaning they contain the same active ingredient and are required to demonstrate equivalent performance, according to regulatory standards.


Q: Do I need to change my diet while taking Lexol?

Official administration guidelines indicate that Lexol oral tablets are intended to be taken with food to ensure optimal absorption. Beyond this specific instruction, unless otherwise advised, a change to the general diet is not usually required.


Q: Is it normal to feel [general symptom, e.g., tired/dizzy] when first starting Lexol?

Official labeling lists dizziness and fatigue as common side effects. Dizziness or lightheadedness are most likely to occur when treatment is started or when the dose is being increased. Some regulatory sources suggest rising slowly from a sitting or lying position to help manage this feeling.


Q: Do the side effects of Lexol usually go away over time?

Some side effects, such as a tingling sensation in the scalp, are noted in official information as being transient, meaning they usually occur when the medication is first initiated. If any symptoms are severe or persist, consulting a healthcare professional is generally recommended.


Q: Does Lexol cause any known long-term problems or changes in the body?

Official warnings mention that severe hepatocellular injury, which is a form of liver injury, has occurred in rare cases with this medication. While often reversible, liver injury has led to more serious outcomes in some instances. Regular monitoring of liver parameters may be required with prolonged use.


Q: Can Lexol affect my ability to drive or operate machinery?

Because common side effects include dizziness and fatigue, official patient information advises caution. Individuals are advised to be aware of how the medication affects them before driving or operating hazardous machinery.


Q: Are there any specific vitamins or supplements that interact with Lexol?

Regulatory documents note that the drug may interact with multivitamin products containing minerals, potentially reducing the medicine's effects. In such cases, official guidance addresses the potential need to separate administration times by at least 2 hours.


Q: Can Lexol be taken by people with kidney problems?

Official drug information states that the time it takes the body to eliminate the drug (half-life) is not typically altered in patients with decreased kidney function. The official guidance notes that caution is required, and use in patients with severe renal impairment has limitations due to limited study data at higher doses.


Q: What happens if I miss a dose of Lexol?

Official patient information states that a missed dose may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is typically skipped, and the regular schedule is continued. Doubling a dose is generally not advised.


Q: What is the risk of dependence or withdrawal if I stop taking Lexol?

Abruptly stopping this medication, a beta-blocker, may worsen chest pain (angina) or, in rare cases, trigger a heart attack in patients with existing coronary artery disease. Because of this risk, official documentation emphasizes that the dosage must be gradually reduced over a period of time, rather than stopped suddenly. This procedure is a measure to help mitigate potential risks.


Q: What are the ingredients in Lexol besides the main active component?

The active ingredient is Labetalol hydrochloride. Official documentation lists various inactive ingredients, which differ depending on the strength and formulation. These often include standard excipients such as anhydrous lactose, carnauba wax, and various colorants.


Q: What should I do if I think I'm having a bad reaction to Lexol?

Official patient information highlights that signs of serious symptoms, such as severe allergic reactions, liver injury, or heart problems, require prompt medical evaluation. Consulting a healthcare professional is advisable at any sign of these serious symptoms.


Q: Can Lexol affect sleep patterns?

Official regulatory documents report drowsiness (somnolence) and, in rare instances, difficulty sleeping (insomnia) as side effects. These reactions could potentially affect a patient’s sleep patterns.


Q: Were there any major studies that supported the approval of Lexol?

The drug’s approval by regulatory bodies was supported by clinical trials that examined its ability to effectively reduce blood pressure. Additionally, bioequivalence studies were required to establish that generic versions of the drug work the same way as the original reference product.


Q: Can Lexol be crushed or cut, or must it be swallowed whole?

Because the official product labeling does not contain instructions for altering the tablet, the tablets are generally intended to be swallowed whole unless a healthcare professional advises otherwise.


Q: Is Lexol known to cause changes in mood or behavior?

Mental and mood changes have been reported as serious but less common side effects associated with the drug. These reported changes include confusion, mood swings, and depression.


Q: Does Lexol have a Boxed Warning (Black Box Warning) in its official labeling?

The current U.S. Prescribing Information for the drug does not contain a Boxed Warning. However, it does include essential warnings regarding the risks associated with abruptly discontinuing the drug, particularly in individuals with pre-existing heart conditions.


Q: What is the importance of taking Lexol at the same time every day?

Taking Lexol at consistent times each day helps the body achieve and maintain steady levels of the drug in the bloodstream. Maintaining these steady levels is necessary for consistent and effective control of blood pressure.


Q: Does Lexol affect laboratory test results?

Official information indicates that the drug may interfere with certain laboratory tests. Specifically, it can cause false-positive results in tests for certain urinary substances (catecholamines), and it may also mask or alter blood or urine sugar test results.


Q: What is meant by the 'half-life' of Lexol?

The half-life is a scientific measurement that describes how long the drug remains active in the body. The plasma elimination half-life of Lexol following oral administration is approximately 6 to 8 hours, which refers to the time it takes for half of the drug to be eliminated from the bloodstream.


Q: Does Lexol affect sexual function?

Official regulatory documents list several effects on sexual function as common side effects. These reported issues include ejaculation failure, impotence (the inability to have or keep an erection), and a decreased interest in sexual intercourse.


Q: What is the risk of overdose with Lexol?

Overdosage with this medication can cause excessively low blood pressure (hypotension), which may be dependent on posture, and a significantly slow heart rate (bradycardia). Other potential symptoms of overdose listed in official documents include lightheadedness, fainting, or seizures.


Q: Can Lexol interact with herbal remedies like St. John's Wort?

Product labeling advises patients to inform their healthcare professional of all herbs and supplements being taken. St. John’s Wort is noted for having potential interactions with many prescription medicines, including some used for blood pressure, and official information indicates it should be taken only under the direction of a healthcare professional.


Q: What is the expected long-term outcome for someone using Lexol for its approved condition?

Studies and official information indicate that long-term reduction and control of blood pressure are associated with decreased cardiovascular risks, such as stroke or heart attack. Lexol is prescribed to help patients achieve and maintain controlled blood pressure levels as a key part of managing this risk.


Q: Are there any known drug-disease interactions with Lexol?

Official warnings and precautions list several conditions that prohibit or restrict the use of Lexol. The medication is contraindicated for patients with active liver disease, bronchial asthma, or overt cardiac failure. Caution is also formally advised for patients with pre-existing hepatic or renal impairment.

How should Lexol be stored and disposed of?

The storage and disposal instructions for Lexol (Labetalol) are officially documented to preserve product integrity and ensure safety, varying slightly between the tablet and intravenous (IV) solution forms.

Storage Requirement Tablets (Oral) IV Solution (Injectable)
Temperature Controlled room temperature (20 C to 25 C). Controlled room temperature (20 C to 25 C).
Environmental Constraints Protect from moisture and excessive heat. Do not freeze; protect from light.
Container Rules Store in a tightly closed container. Store in the original container.

All forms of Lexol must be kept out of the reach and sight of children. The IV solution requires visual inspection for discoloration or particles prior to use, and if diluted, its stability is typically limited to 24 hours. Expired or unused Lexol must be disposed of according to local regulations or a pharmaceutical take-back program, and it should not be discarded in household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lexol found in:

A-Z Index: